Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.13) per share which met the analyst consensus estimate. This is a 30 percent decrease over losses of $(0.10) per share from the same period last year.
A Preview Of Calliditas Therapeutics Earnings
Calliditas Therapeutics (NASDAQ:CALT) is set to give its latest quarterly earnings report on Thursday, 2022-08-18. Here's what investors need to know before the announcement.